'Teach-Back' Communication Strategy Aids Diabetes Outcomes
FRIDAY, Dec. 4, 2020 -- A simple doctor-patient communication technique known as "teach-back" may lower the risk for health complications with diabetes, according to a study published in the November issue of the Journal of the American Board of Family Medicine.
Young-Rock Hong, Ph.D., from the University of Florida in Gainesville, and colleagues examined the patterns of patient teach-back experience to determine its association with risk for diabetic complications, hospitalization, and health expenditures among 2,901 U.S. adults with diabetes identified from the Longitudinal Medical Expenditure Panel Survey (2011 to 2016).
The researchers found that at one-year follow-up, patients with teach-back experience were less likely to develop diabetic complications (adjusted odds ratio, 0.70) and be admitted to the hospital due to diabetic complications (adjusted odds ratio, 0.51). There were also significantly smaller increases in total expenditures among patients with teach-back experience versus those without ($1,920 versus $3,639).
"Patient teach-back is a substantially underused strategy in primary care for those with diabetes, suggesting considerable missed opportunities to enhance the quality of care," the authors write.
© 2021 HealthDay. All rights reserved.
Posted: December 2020
Read this next
FRIDAY, Jan. 22, 2021 -- Consumption of oily fish, but not nonoily fish, is associated with a lower risk for type 2 diabetes (T2D), according to a study published online Jan. 11...
WEDNESDAY, Jan. 20, 2021 -- Abnormalities detected on noninvasive retinal imaging are associated with markers of cognitive dysfunction in older individuals with type 1 diabetes,...
THURSDAY, Jan. 14, 2021 -- Patients with type 2 diabetes adhering to low-carbohydrate diets (LCDs) for six months may experience greater rates of diabetes remission, according to...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.